World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
90
Citations
31875
World Ranking
1070
National Ranking
577

Medicine

D-Index
90
Citations
31685
World Ranking
12159
National Ranking
6236

Clifford V. Harding publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Clifford V. Harding sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 317 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Clifford V. Harding D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Clifford V. Harding sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Clifford V. Harding is affiliated with Case Western Reserve University in the United States. Their scholarly work primarily spans medicine, with a significant focus on immunology and microbiology.

Their research interests encompass several specialized subfields including infectious diseases, immunology, neurology, cardiology and cardiovascular medicine, and hematology. The main themes explored in their work include COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, immune response and inflammation, cardiovascular effects of exercise, long-term effects of COVID-19, SARS-CoV-2 detection and testing, and iron metabolism and disorders.

Frequent coauthors involved in collaborations with Clifford V. Harding include Mina K. Chung, Nancy Nagy, W. Henry Boom, Dhanunjaya Lakkireddy, and Thomas F. Deering.

Publication venues where their research has appeared more than once include The Journal of Immunology and also single publications in EBioMedicine, American Journal of Clinical Pathology, Journal of Alzheimer s Disease, and JACC. Clinical electrophysiology.

Recent selected papers authored or coauthored by Clifford V. Harding include:

  • SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy (2020, EBioMedicine)
  • Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases (2020, American Journal of Clinical Pathology)
  • Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains (2021, Journal of Alzheimer s Disease)
  • Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (2020, JACC. Clinical electrophysiology)
  • Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology (2020, Heart Rhythm)

Clifford V. Harding was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2012.

Best Publications

  • B lymphocytes secrete antigen-presenting vesicles.

    G Raposo;H W Nijman;W Stoorvogel;R Liejendekker

  • Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes

    C Harding;J Heuser;P Stahl

  • CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

    Rose S. Chu;Oleg S. Targoni;Arthur M. Krieg;Paul V. Lehmann

  • Phagocytic processing of bacterial antigens for class I MHC presentation to T cells

    John D. Pfeifer;Mary Jo Wick;Richard L. Roberts;Kirk Findlay

  • Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

    Clifford V. Harding;Emil R. Unanue

  • Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein of Mycobacterium tuberculosis

    Erika H. Noss;Rish K. Pai;Timothy J. Sellati;Justin D. Radolf

  • Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors

    Clifford V. Harding;W. Henry Boom

  • Receptor-mediated endocytosis.

    T. Wileman;Clifford V Harding;P. Stahl

  • Exosomes: Looking back three decades and into the future

    Clifford V. Harding;John E. Heuser;Philip D. Stahl

  • Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.

    Clifford V Harding;Rui Song

  • Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding.

    Clifford V Harding;J. Heuser;P. Stahl

  • Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2

    Nicholas Funderburg;Michael M. Lederman;Zhimin Feng;Michael G. Drage

  • COVID-19 and Cardiovascular Disease: From Bench to Bedside.

    Mina K. Chung;David A. Zidar;Michael R. Bristow;Scott J. Cameron

  • Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.

    Adam J. Gehring;Karen M. Dobos;John T. Belisle;Clifford V. Harding

  • Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors

    Eun Kyeong Jo;Chul Su Yang;Chul Hee Choi;Clifford V. Harding

  • Inhibition of IFN-γ-Induced Class II Transactivator Expression by a 19-kDa Lipoprotein from Mycobacterium tuberculosis: A Potential Mechanism for Immune Evasion

    Rish K. Pai;Marilyn Convery;Thomas A. Hamilton;W. Henry Boom

  • Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells.

    Clifford V Harding;David S Collins;Jan W Slot;Hans J Geuze

  • Reduction of disulfide bonds within lysosomes is a key step in antigen processing

    David S. Collins;Emil R. Unanue;Clifford V. Harding

  • Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling

    Dong Min Shin;Jae Min Yuk;Hye Mi Lee;Sang Hee Lee

  • Extracellular vesicles and infectious diseases: new complexity to an old story

    Jeffrey S. Schorey;Clifford V. Harding

  • Pathways of antigen processing

    Clifford V. Harding

Frequent Co-Authors

W. Henry Boom
W. Henry Boom Case Western Reserve University
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Emil R. Unanue
Emil R. Unanue Washington University in St. Louis
Benigno Rodriguez
Benigno Rodriguez Case Western Reserve University
Wei Jiang
Wei Jiang Wuhan University
Aaron A.R. Tobian
Aaron A.R. Tobian Johns Hopkins University School of Medicine
Arthur M. Krieg
Arthur M. Krieg University of Massachusetts Chan Medical School
Philip D. Stahl
Philip D. Stahl Washington University in St. Louis
Staffan Normark
Staffan Normark Karolinska Institute
Xiaoxia Li
Xiaoxia Li Cleveland Clinic Lerner College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of exciting healthcare careers, often complemented by advanced nursing and practitioner degrees. For those interested in expanding their clinical skills, programs like the accelerated rn to np programs offer a fast-track path from registered nurse to nurse practitioner.

Specializing further, some professionals consider the cheapest psych np programs to reduce education costs while gaining expertise in psychiatric care, a field closely related to immunological disorders that impact mental health.

Understanding the economic landscape is crucial; knowing how much do dnp nurses make across different states can help guide decisions about where to study and work after graduation.

For practicing family nurse practitioners looking to specialize, the fnp to acute care np bridge program provides a structured pathway to transition into acute care settings, often vital when working with immunocompromised patients.

Best Scientists Citing Clifford V. Harding

Trending Scientists